Researchers studied 20 patients who were assigned to 12 weeks of supplemental oxygen for 16 or more hours a day or no oxygen ...

Pulmonary arterial hypertension (PAH) is an increasingly understood disease, with the genetics and pathophysiology mapped out to the extent that new therapies are emerging.1 The epidemiology, however, ...

High blood pressure (hypertension) causes thickening of the blood vessels and hardening of the arteries (arteriosclerosis). A ...

Despite uncertainty around who will sit in The White House in January and what ramifications they may bring, the industry’s ...

Researchers have discovered four critical genes linked to Pulmonary Arterial Hypertension (PAH), paving the way for ...

One of the key highlights was the discussion of Pulmonary Embolism Response Teams (PERT), addressing controversies in PE management and focusing on personalized, patient-centered care.

The global pulmonary arterial hypertension treatment market is on track to achieve significant growth over the next decade, with a projected valuation of USD 7,224.4 million by 2033. This expansion ...

Exosomes released by mesenchymal stem cells may help reduce vascular remodeling and ease PH symptoms, a rat study showed.

Experts explored the latest trends, approvals, and pipeline developments in cell and gene therapies, rare disease, immunology ...

Analyst Cory Jubinville, PhD from LifeSci Capital maintained a Buy rating on Liquidia Technologies (LQDA – Research Report) and keeping ...

Objectives To update the 2017 European Alliance of Associations for Rheumatology (EULAR) recommendations for treatment of ...

The Pulmonary Hypertension Association's "Let Your Light Shine" campaign ... The global PH community is encouraged to participate by advocating for better care and treatment access, volunteering to ...